Member Info for Mulder

Oversold on all technicals.

First one in a while. Lets hope it is the start of a Santa rally for Debenhams also! Only 8 trading days to Xmas.

They (alone) have been shorting Saga for years and have been reducing their position actually GLG Partners LP 0.39% 16 Nov 2017 - last disclosed position GLG Partners LP 0.50% 31 Oct 2017 GLG Partners LP 0.45% 13 Oct 2017 GLG Partners LP 0.52% 5 Oct 2017 GLG Partners LP 0.49% 7 Aug 2017 GLG Partners LP 0.50% 13 Jul 2017 GLG Partners LP 0.42% 27 Feb 2015 GLG Partners LP 0.59% 29 Oct 2014 GLG Partners LP 0.60% 24 Oct 2014 https://shorttracker.co.uk/company/GB00BLT1Y088/

Just to re-iterate a share is considered oversold when the RSI drops below 30; the current RSI here is 11. What term would be used for an RSI of 11 - extremely/massively oversold? The 2 year and 5 year RSI's are just 12. Williams Score -99.6% When the rise comes I suspect it will be swift. FYI the FCA short tracker is not disclosing any positions for Saga. The mere fact people are looking in here and posting means they are interested in the company and looking to buy in. ftsemajor - looks like your target of 125p is nearly here. The selling has to stop at some stage and buyers will return to get us to a more sensible RSI in the 30's and 40's.

12 December 2017 DRAX GROUP PLC (Symbol: DRX) Trading Update Drax today publishes a trading update for the period from 1 July 2017 to date. Trading and Operational Performance Since publishing its half year results on 19 July 2017, trading conditions in the markets in which Drax operates have remained in line with expectations.

Any thinking behind that number or was it just plucked out of thin air? FYI your buy in price is even lower than the NAV/book price here.

ROA is 4 and ROE is 10 here which is better than M&S for example.

Most M&A's apply a 30% premium to the closing SP on that day. A 30% premium here gets you to 166p which is still far below the 180p+ the SP has been trading at since flotation. Gross profits of £450M+ and a loyal over 50's customer base. Could be a bargain for ~ £1.8Bn.

I saw this skullduggery with Spire recently. SP fell a similar amount to 220p, broker downgrades, low RSI etc then suddenly an offer of 315p appeared. Even there the RSI dropped to 14-15 but not 11. Gross profit of £450M last year and this year will still rise another 1-2% even after the revised guidance. Revenues of £900M Fall overdone IMO

RSI down to just 11; technical bounce imminent?

The higher oil prices will easily cover the dividend.

Centrica is one of the top gas producers on the UK Continental Shelf and Exploration and Production (E&P) remains an important part of the Group. Centrica has launched a new company as a joint venture with Norwegian energy firm Bayerngas Norge. Spirit Energy, an exploration and production (E&P) company, is the result of a combination of Centrica's E&P business and Bayerngas. Former shareholders in Bayerngas now own 31 per cent of the newly formed company and Centrica owns the other 69 per cent By combining the two businesses, the total 2017 production is expected to reach 50m barrels of oil equivalent from 27 producing fields. *************************************************************************************** 50m barrels @ $60/barrel = $3 Billion in revenue Cost per barrel ~ $30 Profit therefore of $30/barrel x 50 million = $1.5 billion profit Capex ~ $650M/year Net profit ~ $850M of which Centrica entitled to 69% = $587M Oil price is actually higher currently at $65/barrel E&P profits last year though were only £99M admittedly with a lower oil price of $40-$45 This alone would boost Centrica profits significantly. Thoughts?

Following recent price action, Hikma Pharmaceuticals Plc (HIK.L) shares have been identified trading above the Chikou. When the stock is above this signal, traders will be looking out for possible upward momentum. Investors may be looking to compare the current stock price of Hikma Pharmaceuticals Plc (HIK.L) to some of its moving averages. After a recent check, the 200-day MA is resting at 1498.34, and the 50-day is 1109.40. Moving averages are considered to be lagging indicators that simply take the average price of a stock over a specific period of time. Moving averages can be very useful for identifying peaks and troughs. They may also be used to help the trader figure out proper support and resistance levels for the stock. Traders may also be paying close attention to RSI levels on shares of Hikma Pharmaceuticals Plc (HIK.L). The current 14-day RSI is presently sitting at 35.20, the 7-day is 27.37, and the 3-day is 5.74. The RSI, or Relative Strength Index is a popular oscillating indicator among traders and investors. The RSI operates in a range-bound area with values between 0 and 100. When the RSI line moves up, the stock may be experiencing strength. The opposite is the case when the RSI line is heading lower. Different time periods may be used when using the RSI indicator. The RSI may be more volatile using a shorter period of time. Many traders keep an eye on the 30 and 70 marks on the RSI scale. A move above 70 is widely considered to show the stock as overbought, and a move below 30 would indicate that the stock may be oversold. Traders may use these levels to help identify stock price reversals

RSI 12

Holdings RNS showing a rise. Chart looking bullish for a rise back to 1100p+

RSI 23 (oversold) I may be wrong but using charts I see support around 32-33p.

An RSI<30 is considered oversold. Current 1 year RSI here is 13 2 year RSI is just 12 (!) A 10-15% bounce is normally expected at such levels.

Yet there's a scenario where a new chairman implements a fresh review and either installs new top management or breaks it up to exact value on a sum-of-parts basis. For what it's worth, Goldman Sachs (which floated Saga) has entertained 230p per share. For a hedge fund with a £1 billion war chest for pro-active investing, Saga could be a lucrative target

If any of you fancy a punt SAGA which I'm sure you've heard of is now one of the most oversold stocks on the entire FTSE with an RSI of 14. Ripe for a rebound.

It's a marker of how bought or sold a share is. Any share with RSI<30 is considered oversold >70 overbought Most shares range between 30-60 hence why 8 was possibly the lowest I've seen.